ZY
Zydus Lifesciences
ZYDUSLIFE.NS·NSEAhmedabad INFounded 195225,000 employees
Large CappharmaPublicOncologyMetabolic
Platform: NCE Discovery
Market Cap
$12B
All Drugs
5
Clinical Trials
8
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (ZYDUSLIFE.NS)
Loading ZYDUSLIFE.NS stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ZYD-7355 | ZYD-7355 | Phase 1 | 1 | VEGF | Melanoma | ||
| Ceviglumide | ZYD-6260 | Phase 3 | 2 | IL-17A | Urothelial CaPompe | ||
| ZYD-5095 | ZYD-5095 | Phase 2 | 1 | TIM-3 | PTSD | ||
| Teracagene | ZYD-8929 | Phase 2 | 2 | Nectin-4 | ET | ||
| ZYD-981 | ZYD-981 | Preclinical | 2 | TIGIT | AsthmaADPKD |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Zydus Lifesciences trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (9)